z-logo
open-access-imgOpen Access
Impaired cognition predicts the risk of hospitalization and death in cirrhosis
Author(s) -
Kim Minjee,
Liotta Eric M.,
Zee Phyllis C.,
Ganger Daniel R.,
Ladner Daniela P.,
Karmarkar Ameeta,
Peipert John D.,
Sorond Farzaneh A.,
Prabhakaran Shyam,
Reid Kathryn J.,
Naidech Andrew M.,
Maas Matthew B.
Publication year - 2019
Publication title -
annals of clinical and translational neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.824
H-Index - 42
ISSN - 2328-9503
DOI - 10.1002/acn3.50924
Subject(s) - medicine , hepatic encephalopathy , cognition , cirrhosis , observational study , prospective cohort study , cognitive test , delirium , intensive care medicine , psychiatry
Objective Cognitive impairment, detected in up to 80% of patients with liver cirrhosis, is associated with negative health outcomes but is underdiagnosed in the clinical setting due to the lack of practical testing method. This single‐center prospective observational study aimed to test the feasibility and prognostic utility of in‐clinic cognitive assessment of patients with liver cirrhosis using the NIH Toolbox cognition battery (NIHTB). Methods Patients recruited from a hepatology/transplant clinic underwent cognitive assessments using West‐Haven Grade (WHG) and NIHTB between November 2016 and August 2018 and were prospectively followed until December 2018. The primary outcome was a composite end point of hospitalization related to overt hepatic encephalopathy (OHE) and all‐cause mortality during follow‐up, evaluated by a Cox proportional hazards regression model that adjusted for a priori covariates (age and MELD‐Na). Results Among 127 patients (median age 60 years, 48 [38%] women) assessed, cognitive performance was significantly impaired in 82 [78%] patients with WHG 0 and 22 [100%] patients with WHG 1 and 2. Over a median of 347 days follow‐up, 18 OHE and 8 deaths were observed. Lower cognitive performance was associated with an increased risk of OHE/death adjusting for age and MELD‐Na. Subclinical cognitive impairment detected by NIH Toolbox in WHG 0 patients was significantly associated with greater mortality. Median time to complete the two prognostically informative NIH Toolbox tests was 9.4 min. Interpretation NIH Toolbox may enable a rapid cognitive screening in the outpatient setting and identify patients at high risk for death and hospitalization for severe encephalopathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here